AstraZeneca (AZN) Reports Q1 Core EPS of $0.99

AstraZeneca (NYSE: AZN) reported Q1 EPS of $0.99. Revenue for the quarter came in at $5.4 billion versus the consensus estimate of $5.22 billion.

For earnings history and earnings-related data on AstraZeneca (AZN) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• AeroVironment restates quarterly financials, citing $89M goodwill error
• Prosperity Bancshares (PB) Reiterated at Overweight by Cantor Fitzgerald as Estimates Revised